Senseonics Holdings, Inc. Common Stock (NYSE MKT:SENS) — Market Cap & Net Worth
Market Cap & Net Worth: Senseonics Holdings, Inc. Common Stock (SENS)
Senseonics Holdings, Inc. Common Stock (NYSE MKT:SENS) has a market capitalization of $259.04 Million ($259.04 Million) as of September 17, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #15588 globally and #3687 in its home market, demonstrating a 8.93% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Senseonics Holdings, Inc. Common Stock's stock price $6.34 by its total outstanding shares 40858460 (40.86 Million). Also see SENS total asset value for a full breakdown of the balance sheet.
Senseonics Holdings, Inc. Common Stock Market Cap History: 2015 to 2026
Senseonics Holdings, Inc. Common Stock's market capitalization history from 2015 to 2026. Data shows growth from $132.79 Million to $259.04 Million (6.62% CAGR). Also see SENS operating cash flow for how efficiently the company converts equity into cash flow.
Senseonics Holdings, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Senseonics Holdings, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check SENS stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.95x
Senseonics Holdings, Inc. Common Stock's market cap is 0.95 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $132.79 Million | $38.00K | -$29.88 Million | 3494.47x | N/A |
| 2016 | $109.09 Million | $332.00K | -$43.93 Million | 328.59x | N/A |
| 2017 | $108.68 Million | $6.37 Million | -$59.10 Million | 17.05x | N/A |
| 2018 | $105.82 Million | $18.91 Million | -$93.97 Million | 5.60x | N/A |
| 2019 | $37.43 Million | $21.30 Million | -$115.55 Million | 1.76x | N/A |
| 2020 | $35.62 Million | $4.95 Million | -$175.17 Million | 7.20x | N/A |
| 2021 | $109.09 Million | $13.68 Million | -$302.47 Million | 7.98x | N/A |
| 2022 | $42.08 Million | $16.39 Million | $142.12 Million | 2.57x | 0.30x |
| 2023 | $23.29 Million | $22.39 Million | -$60.39 Million | 1.04x | N/A |
| 2024 | $21.39 Million | $22.47 Million | -$78.62 Million | 0.95x | N/A |
Competitor Companies of SENS by Market Capitalization
Companies near Senseonics Holdings, Inc. Common Stock in the global market cap rankings as of September 17, 2026. Review tangible net worth ratio of Senseonics Holdings, Inc. Common Stock to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Senseonics Holdings, Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Senseonics Holdings, Inc. Common Stock Historical Marketcap From 2015 to 2026
Between 2015 and today, Senseonics Holdings, Inc. Common Stock's market cap moved from $132.79 Million to $ 259.04 Million, with a yearly change of 6.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $259.04 Million | +14.86% |
| 2025 | $225.54 Million | +954.64% |
| 2024 | $21.39 Million | -8.19% |
| 2023 | $23.29 Million | -44.65% |
| 2022 | $42.08 Million | -61.42% |
| 2021 | $109.09 Million | +206.26% |
| 2020 | $35.62 Million | -4.83% |
| 2019 | $37.43 Million | -64.63% |
| 2018 | $105.82 Million | -2.63% |
| 2017 | $108.68 Million | -0.37% |
| 2016 | $109.09 Million | -17.85% |
| 2015 | $132.79 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Senseonics Holdings, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $259.04 Million USD |
| MoneyControl | $259.04 Million USD |
| MarketWatch | $259.04 Million USD |
| marketcap.company | $259.04 Million USD |
| Reuters | $259.04 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabet… Read more